AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2020
Mar 30, 2020
31201_dirs_2020-03-30_5b5d75c9-7000-4c76-acf4-48114a07ba94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2020-03-27
Reporting Person: Hassanein Waleed H (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-27 | Common Stock | M | 100000 | $0.39 | Acquired | 215429 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-27 | Stock Option (Right to Buy) | $0.39 | M | 100000 | Disposed | 2021-09-21 | Common | |
| Stock (100000) | Direct |
Footnotes
F1: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20